메뉴 건너뛰기




Volumn 160, Issue 2, 1998, Pages 551-555

Vasoactive cocktails for erectile dysfunction: Chemical stability of PGE1, papaverine and phentolamine

Author keywords

Impotence; Papaverine; Phentolamine; Prostaglandin E1; Vasoactive cocktails

Indexed keywords

PAPAVERINE; PHENTOLAMINE; PHENTOLAMINE MESYLATE; PROSTAGLANDIN E1; VASOACTIVE AGENT;

EID: 0032324145     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62957-4     Document Type: Article
Times cited : (13)

References (22)
  • 2
    • 0024510013 scopus 로고
    • Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: A double-blind comparison
    • Lee, L. M., Stevenson, R. W. and Szasz, G.: Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. J. Urol., 141: 549, 1989.
    • (1989) J. Urol. , vol.141 , pp. 549
    • Lee, L.M.1    Stevenson, R.W.2
  • 3
    • 0001231183 scopus 로고
    • Rescuing the failed papaverine-phentolamine erection: A proposed synergistic action of papaverine phentolamine, and PGE1
    • Goldstein, I., Borges, F. D. and Fitch, W. P.: Rescuing the failed papaverine-phentolamine erection: a proposed synergistic action of papaverine phentolamine, and PGE1. J. Urol., 143: 304A, 1990.
    • (1990) J. Urol. , vol.143
    • Goldstein, I.1    Borges, F.D.2    Fitch, W.P.3
  • 6
    • 0001621482 scopus 로고
    • A comparison of the response to the intracavernosal injection of a combination of papaverine and phentolamine, prostaglandin PGE1 and a combination of all three agents in the management of impotence
    • McMahon, C. G.: A comparison of the response to the intracavernosal injection of a combination of papaverine and phentolamine, prostaglandin PGE1 and a combination of all three agents in the management of impotence. Int. J. Impotence Res., 3: 113, 1991.
    • (1991) Int. J. Impotence Res. , vol.3 , pp. 113
    • McMahon, C.G.1
  • 7
    • 0026549153 scopus 로고
    • Comparison of effects following the intracorporeal injection of papaverine and prostaglandin
    • Chen, J. K., Hwang, T. I. S. and Yang, C.: R.: Comparison of effects following the intracorporeal injection of papaverine and prostaglandin El. Br J. Urol., 69: 404, 1992.
    • (1992) El. Br J. Urol. , vol.69 , pp. 404
    • Chen, J.K.1    Hwang, T.I.S.2    Yang, C.R.3
  • 8
    • 0028963252 scopus 로고
    • Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC)
    • Gatti, R., Gotti, R., Cavrini, V., Soli, M., Bertaccini, A. and Carparelli, F.: Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC). Int. J. Pharm., 115: 103, 1995.
    • (1995) Int. J. Pharm. , vol.115 , pp. 103
    • Gatti, R.1    Gotti, R.2    Cavrini, V.3    Soli, M.4    Bertaccini, A.5    Carparelli, F.6
  • 9
    • 0344940148 scopus 로고    scopus 로고
    • First comparison of alprostadil sterile powder (Caverject) with tri-mix nomogram and patient satisfaction
    • Hakim, L. S., Nehra, A. and Goldstein, L: First comparison of alprostadil sterile powder (Caverject) with tri-mix nomogram and patient satisfaction. Int. J. Imp. Res., 8: 113, 1996.
    • (1996) Int. J. Imp. Res. , vol.8 , pp. 113
    • Hakim, L.S.1    Nehra, A.2    Goldstein, L.3
  • 10
    • 0030045472 scopus 로고    scopus 로고
    • Alprostadil sterile powder formulation for intracavernous treatment of erectile dysfunction
    • Colli, E., Calabro, A., Gentile, V., Mirone, V. and Soli, M.: Alprostadil sterile powder formulation for intracavernous treatment of erectile dysfunction. Eur. Urol., 29:, 1996.
    • (1996) Eur. Urol. , vol.29
    • Colli, E.1    Calabro, A.2    Gentile, V.3    Mirone, V.4    Soli, M.5
  • 11
    • 0000042220 scopus 로고
    • Combination intracavernous pharmacotherapy in the management of male erectile dysfunction
    • Hamid, S., Dhabuwala, C. B. and Pontes, E. J,: Combination intracavernous pharmacotherapy in the management of male erectile dysfunction. Int. J. Impotence Res., 4: 109, 1992.
    • (1992) Int. J. Impotence Res. , vol.4 , pp. 109
    • Hamid, S.1    Dhabuwala, C.B.2    Pontes, E.J.3
  • 13
    • 0029166198 scopus 로고
    • Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: A clinical double-blind study
    • Shenfeld, O., Hanani, J., Shalhav, A., Vardi, Y.and Goldwasser, B.: Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study. J. Urol., 154: , 1995.
    • (1995) J. Urol. , vol.154
    • Shenfeld, O.1    Hanani, J.2    Shalhav, A.3    Vardi, Y.4    Goldwasser, B.5
  • 14
    • 0024215815 scopus 로고
    • Erectile responses to intracavernous papaverine and phentolamine: Comparison of single and combined delivery
    • Stief, C. G. and Wetterauer, U.: Erectile responses to intracavernous papaverine and phentolamine: comparison of single and combined delivery. J. Urol., 140: 1415, 1988.
    • (1988) J. Urol. , vol.140 , pp. 1415
    • Stief, C.G.1    Wetterauer, U.2
  • 15
    • 0026086806 scopus 로고
    • Intravenous self-injection of vasoactive drugs in the treatment of impotence: 8 years experience with 615 cases
    • Virag, R., Shoukry, K. and Floresco, J.: Intravenous self-injection of vasoactive drugs in the treatment of impotence: 8 years experience with 615 cases. J. Urol., 145: 287, 1991.
    • (1991) J. Urol. , vol.145 , pp. 287
    • Virag, R.1    Shoukry, K.2    Floresco, J.3
  • 16
    • 0024405482 scopus 로고
    • Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents
    • Kiely, E. A., Bloom, S. R. and Williams, G.: Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents. Br. J. Urol., 64: 191, 1989.
    • (1989) Br. J. Urol. , vol.64 , pp. 191
    • Kiely, E.A.1    Bloom, S.R.2    Williams, G.3
  • 17
    • 0030333542 scopus 로고    scopus 로고
    • A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction
    • McMahon, C. G.: A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction. Int. J. Imp. Res., 8: 115,1996.
    • (1996) Int. J. Imp. Res. , vol.8 , pp. 115
    • McMahon, C.G.1
  • 18
    • 0027308775 scopus 로고
    • Prostaglandin E, and the nitric oxide donor linsidomine for erectile failure: A diagnostic comparative study of 40 patients
    • Porst H.: Prostaglandin E, and the nitric oxide donor linsidomine for erectile failure: a diagnostic comparative study of 40 patients. J. Urol., 149: 1280, 1993.
    • (1993) J. Urol. , vol.149 , pp. 1280
    • Porst, H.1
  • 20
    • 0029967490 scopus 로고    scopus 로고
    • Forskolin: A promising new adjunct to intracavernous pharmacotherapy
    • Cahn, D., Melman, A., Valcic, M. and Christ, G. J.: Forskolin: a promising new adjunct to intracavernous pharmacotherapy. J. Urol., 155: 1789, 1996.
    • (1996) J. Urol. , vol.155 , pp. 1789
    • Cahn, D.1    Melman, A.2    Valcic, M.3    Christ, G.J.4
  • 21
    • 0027266895 scopus 로고
    • Follow up results of a combination of calcitonin gene related peptide and prostaglandin E1 in the treatment of erectile dysfunction
    • Djamilian, M., Stief, C., Kuczyk, M. and Jonas, U.: Follow up results of a combination of calcitonin gene related peptide and prostaglandin E1 in the treatment of erectile dysfunction. J. Urol., 149: 1296, 1993.
    • (1993) J. Urol. , vol.149 , pp. 1296
    • Djamilian, M.1    Stief, C.2    Kuczyk, M.3    Jonas, U.4
  • 22
    • 0024412148 scopus 로고
    • The pH analysis of papaverine - Phentolamine and prostaglandin E1 for pharmacologic erection
    • Seidmon, E. J. and Samaha, A. M. Jr.: The pH analysis of papaverine - phentolamine and prostaglandin E1 for pharmacologic erection. J. Urol., 141: 1458, 1989.
    • (1989) J. Urol. , vol.141 , pp. 1458
    • Seidmon, E.J.1    Samaha A.M., Jr.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.